Continuum Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1K Buy
+36
New +$3.16K ﹤0.01% 1615
2025
Q2
Sell
-280
Closed -$31.7K 1620
2025
Q1
$31.7K Sell
280
-117
-29% -$12.5K ﹤0.01% 773
2024
Q4
$41.9K Buy
397
+7
+2% +$751 0.01% 694
2024
Q3
$42.5K Sell
390
-22
-5% -$2.4K 0.01% 688
2024
Q2
$44.7K Buy
412
+2
+0.5% +$236 0.01% 629
2024
Q1
$49.8K Buy
+410
New +$51.2K 0.01% 600

Other funds holding ZBH

Continuum Advisory's ZBH Position: Q2 2026 in Review

Continuum Advisory opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 36 shares worth $3.1K. The stake represents ﹤0.01% of the portfolio and ranks #1615 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in ZBH as recently as Q1 2025.

Continuum Advisory first reported a position in ZBH in Q1 2024 and has held it in 6 quarters since. The position peaked at $49.8K in Q1 2024. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Continuum Advisory held 36 shares of Zimmer Biomet worth $3.1K as of Q2 2026.
  • Zimmer Biomet was a new Continuum Advisory position in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1615 holding.
  • Continuum Advisory first reported a position in Zimmer Biomet in Q1 2024 and has held it in 6 quarters since.
  • Continuum Advisory's Zimmer Biomet position peaked at $49.8K in Q1 2024.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.